Influence of pain treatment by epidural fentanyl and bupivacaine on homing of opioid-containing leukocytes to surgical wounds.
Endogenous opioids released from leukocytes extravasating into injured tissue can interact with peripheral opioid receptors to inhibit nociception. Animal studies have shown that the homing of opioid-producing leukocytes to the injured site is modulated by spinal blockade of noxious input. This study investigated whether epidural analgesia (EDA) influences the migration of beta-endorphin (END) and/or met-enkephalin (ENK)-containing leukocytes into the subcutaneous wound tissue of patients undergoing abdominal surgery. In part I patients received general anesthesia combined either with intra- and postoperative EDA (with bupivacaine and fentanyl) or with postoperative patient controlled intravenous analgesia (PCIA; with the opioid piritramide). In part II patients received general anesthesia combined with either epidural fentanyl or bupivacaine which was continued postoperatively. Samples of cutanous and subcutanous tissue were taken from the wound site at the beginning, at the end and at various times after surgery, and were examined by immunohistochemistry for the presence of END and ENK. We found that (i) epidural bupivacaine, fentanyl and PCIA provided similar and clinically acceptable postoperative pain relief; (ii) compared to PCIA, epidural bupivacaine or fentanyl did not change the gross inflammatory reaction within the surgical wound; (iii) opioid-containing leukocytes were almost absent in normal subcutaneous tissue but migrated to the inflamed wound tissue in ascending numbers within a few hours, reaching a peak at about 24 h after surgery; (iv) compared to PCIA, EDA resulted in significantly decreased homing of END-containing leukocytes to the injured site at 24 h after surgery; and (v) the magnitude of this decrease was similar regardless of the epidural medication. These findings suggest that nociceptive but not sympathetic neurons are primarily involved in the attraction of opioid-containing leukocytes during early stages of inflammation.
Heurich
Martin
M
Klinik für Anaesthesiologie und operative Intensivmedizin, Charité-Universitätsmedizin Berlin, Campus Benjamin Franklin, Hindenburgdamm 30, D-12200 Berlin, Germany. martin.heurich@charite.de
Mousa
Shaaban A
SA
Lenzner
Moritz
M
Morciniec
Pawel
P
Kopf
Andreas
A
Welte
Martin
M
Stein
Christoph
C
D000759:Adjuvants, Anesthesia / Q000276:immunology / Q000494:pharmacology; D000368:Aged; D016058:Analgesia, Patient-Controlled; D000701:Analgesics, Opioid / Q000276:immunology* / Q000627:therapeutic use; D000767:Anesthesia, Epidural; D000779:Anesthetics, Local / Q000276:immunology / Q000627:therapeutic use; D002045:Bupivacaine / Q000276:immunology / Q000627:therapeutic use; D002465:Cell Movement / Q000187:drug effects* / Q000276:immunology; D004744:Enkephalin, Methionine / Q000187:drug effects / Q000276:immunology / Q000378:metabolism*; D005260:Female; D005283:Fentanyl / Q000276:immunology / Q000627:therapeutic use; D006801:Humans; D007962:Leukocytes / Q000187:drug effects* / Q000276:immunology / Q000378:metabolism; D008137:Longitudinal Studies; D008297:Male; D008875:Middle Aged; D009619:Nociceptors / Q000187:drug effects / Q000276:immunology; D010149:Postoperative Pain / Q000276:immunology / Q000517:prevention & control; D010892:Pirinitramide / Q000627:therapeutic use; D040521:Subcutaneous Tissue / Q000276:immunology; D017779:Sympathetic Fibers, Postganglionic / Q000187:drug effects / Q000276:immunology; D014945:Wound Healing / Q000187:drug effects / Q000276:immunology*; D001615:beta-Endorphin / Q000187:drug effects / Q000276:immunology / Q000378:metabolism*
D000759:Adjuvants, Anesthesia; D000701:Analgesics, Opioid; D000779:Anesthetics, Local; D010892:Pirinitramide; D004744:Enkephalin, Methionine; D001615:beta-Endorphin; D005283:Fentanyl; D002045:Bupivacaine